RE:RE:RE:Here’s the problemWe shall see.
A lot depends on what the FDA do when they will see the audit analysis.
ACST is convinced that the FDA will cooperate as it won't be able to turn their back to the audit analysis. The goal is to have the weight of those sites reduced or eliminated completely as it makes no sense. And there is an old saying: "when something doesn't make sense, it's not true".